{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:36:46Z","timestamp":1791319006697,"version":"4.3.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1186\/bcr426","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T08:07:27Z","timestamp":1033027647000},"source":"Crossref","is-referenced-by-count":320,"title":["The p53 pathway in breast cancer"],"prefix":"10.1186","volume":"4","author":[{"given":"Milena","family":"Gasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukri","family":"Shami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,4,1]]},"reference":[{"key":"430_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2001","unstructured":"Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature. 2001, 408: 307-310. 10.1038\/35042675.","journal-title":"Nature"},{"key":"430_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1006\/scbi.1998.0097","volume":"8","author":"WS el-Deiry","year":"1998","unstructured":"el-Deiry WS: Regulation of p53 downstream genes. Semin Cancer Biol. 1998, 8: 345-357. 10.1006\/scbi.1998.0097.","journal-title":"Semin Cancer Biol"},{"key":"430_CR3","first-page":"6788","volume":"60","author":"A Sigal","year":"2000","unstructured":"Sigal A, Rotter V: Oncogenic mutations of the p53 tumor suppressor: The demons of the guardian of the genome. Cancer Res. 2000, 60: 6788-6793.","journal-title":"Cancer Res"},{"key":"430_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1383-5742(00)00015-6","volume":"462","author":"SP Hussain","year":"2000","unstructured":"Hussain SP, Harris CC: Molecular epidemiology and carcino-genesis: endogenous and exogenous carcinogens. Mutat Res. 2000, 462: 311-322. 10.1016\/S1383-5742(00)00015-6.","journal-title":"Mutat Res"},{"key":"430_CR5","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990, 250: 1233-1238.","journal-title":"Science"},{"key":"430_CR6","first-page":"893","volume":"5","author":"J Bartek","year":"1990","unstructured":"Bartek J, Iggo R, Gannon J, Lane DP: Genetic and immunocytochemical analysis of mutant p53 in human breast cancer. Oncogene. 1990, 5: 893-899.","journal-title":"Oncogene"},{"key":"430_CR7","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1073\/pnas.88.11.5006","volume":"88","author":"AM Davidoff","year":"1991","unstructured":"Davidoff AM, Humphrey PA, Iglehart JD, Marks JR: Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci USA. 1991, 88: 5006-5010.","journal-title":"Proc Natl Acad Sci USA"},{"key":"430_CR8","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1038\/sj.bjc.6690628","volume":"80","author":"PD Pharaoh","year":"1999","unstructured":"Pharaoh PD, Day NE, Caldas C: Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer. 1999, 80: 1968-1973. 10.1038\/sj.bjc.6690628.","journal-title":"Br J Cancer"},{"key":"430_CR9","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/jnci\/93.9.700","volume":"93","author":"SJ Done","year":"2001","unstructured":"Done SJ, Eskandarian S, Bull S, Redston M, Andrulis IL: p53 mis-sense mutations in microdissected high-grade ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2001, 93: 700-704. 10.1093\/jnci\/93.9.700.","journal-title":"J Natl Cancer Inst"},{"key":"430_CR10","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1038\/sj.onc.1202565","volume":"18","author":"PD Smith","year":"1999","unstructured":"Smith PD, Crossland S, Parker G, Osin P, Brooks L, Waller J, Philp E, Crompton MR, Gusterson BA, Allday MJ, Crook T: Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions. Oncogene. 1999, 18: 2451-2459. 10.1038\/sj\/onc\/1202565.","journal-title":"Oncogene"},{"key":"430_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/jnci\/91.5.469","volume":"91","author":"KA Phillips","year":"1999","unstructured":"Phillips KA, Nichol K, Ozcelik H, Knight J, Done SJ, Goodwin PJ, Andrulis IL: Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations. J Natl Cancer Inst. 1999, 91: 469-473. 10.1093\/jnci\/91.5.469.","journal-title":"J Natl Cancer Inst"},{"key":"430_CR12","first-page":"4092","volume":"61","author":"MS Greenblatt","year":"2001","unstructured":"Greenblatt MS, Chappuis PO, Bond JP, Hamel N, Foulkes WD: TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. Cancer Res. 2001, 61: 4092-4097.","journal-title":"Cancer Res"},{"key":"430_CR13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/jnci\/91.7.641","volume":"91","author":"P De Cremoux","year":"1999","unstructured":"De Cremoux P, Salomon AV, Liva S, Dendale R, Bouchind'homme B, Martin E, Sastre-Garau X, Magdelenat H, Fourquet A, Soussi T: p53 mutation as a genetic trait of typical medullary breast carcinoma. J Natl Cancer Inst. 1999, 91: 641-643. 10.1093\/jnci\/91.7.641.","journal-title":"J Natl Cancer Inst"},{"key":"430_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","volume":"92","author":"M Esteller","year":"2001","unstructured":"Esteller M, Silva JM, Domingue G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB, Herman JG: Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst. 2001, 92: 564-569. 10.1093\/jnci\/92.7.564.","journal-title":"J Natl Cancer Inst"},{"key":"430_CR15","doi-asserted-by":"publisher","first-page":"7262","DOI":"10.1073\/pnas.89.15.7262","volume":"89","author":"UM Moll","year":"1992","unstructured":"Moll UM, Riou G, Levine AJ: Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA. 1992, 89: 7262-7266.","journal-title":"Proc Natl Acad Sci USA"},{"key":"430_CR16","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1086\/301706","volume":"62","author":"T Stankovic","year":"1998","unstructured":"Stankovic T, Kidd AM, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ, Taylor AM: ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet. 1998, 62: 334-345. 10.1086\/301706.","journal-title":"Am J Hum Genet"},{"key":"430_CR17","first-page":"7608","volume":"61","author":"T Dork","year":"2001","unstructured":"Dork T, Bendix R, Bremer M, Rades D, Klopper K, Nicke M, Skawran B, Hector A, Yamini P, Steinmann D, Weise S, Stuhrmann M, Karstens JH: Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res. 2001, 61: 7608-7615.","journal-title":"Cancer Res"},{"key":"430_CR18","first-page":"3536","volume":"6","author":"S Angele","year":"2000","unstructured":"Angele S, Treilleux I, Taniere P, Martel-Planche G, Villaume M, Bailly C, Bremond A, Montesano R, Hall J: Abnormal expression of the ATM and TP53 genes in sporadic breast cancer. Clin Cancer Res. 2000, 6: 3536-3544.","journal-title":"Clin Cancer Res"},{"key":"430_CR19","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1126\/science.286.5449.2528","volume":"286","author":"DW Bell","year":"1999","unstructured":"Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF, Birch JM, Li FP, Garber JE, Haber DA: Heterozygous germ line hCHK2 mutations in Li\u2013Fraumeni syndrome. Science. 1999, 286: 2528-2531. 10.1126\/science.286.5449.2528.","journal-title":"Science"},{"key":"430_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1054\/bjoc.2001.1858","volume":"85","author":"M Allinen","year":"2001","unstructured":"Allinen M, Huusko P, Mantyniemi S, Launonen V, Wingvist R: Mutation analysis of the CHK2 gene in families with hereditary breast cancer. Br J Cancer. 2001, 85: 209-212. 10.1054\/bjoc.2001.1858.","journal-title":"Br J Cancer"},{"key":"430_CR21","first-page":"5718","volume":"61","author":"P Vahteristo","year":"2001","unstructured":"Vahteristo P, Tamminen A, Karvinen P, Eerola H, Eklund C, Aalto-nen LA, Blomqvist C, Aittomaki K, Nevanlinna H: p53, CHK2, and CHK1 genes in Finnish families with Li\u2013Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Cancer Res. 2001, 61: 5718-5722.","journal-title":"Cancer Res"},{"key":"430_CR22","volume-title":"Oncogene","author":"A Sullivan","year":"2002","unstructured":"Sullivan A, Yuille M, Repellin C, Reddy A, Olivier Reelfs O, Bell A, Dunne B, Gusterson BA, Osin P, Farrell PJ, Yulug I, Evans A, Ozcelik T, Gasco M, Crook T: Concomitant inactivation of p53 and Chk2 in breast cancer. Oncogene. 2002,"},{"key":"430_CR23","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/35016125","volume":"405","author":"V Raman","year":"2000","unstructured":"Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, Sukumar S: Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature. 2000, 405: 974-978. 10.1038\/35016125.","journal-title":"Nature"},{"key":"430_CR24","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1073\/pnas.100566997","volume":"97","author":"AT Ferguson","year":"2000","unstructured":"Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, Marks JR, Lambers AR, Futreal PA, Stampfer MR, Sukumar S: High frequency of hypermethylation at the 14-3-3\u03c3 locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA. 2000, 97: 6049-6054. 10.1073\/pnas.100566997.","journal-title":"Proc Natl Acad Sci USA"},{"key":"430_CR25","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1038\/sj.onc.1204438","volume":"20","author":"CB Umbricht","year":"2001","unstructured":"Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S: Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene. 2001, 20: 3348-3353. 10.1038\/sj.onc.1204438.","journal-title":"Oncogene"},{"key":"430_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1023\/A:1010686518990","volume":"65","author":"GH Ho","year":"2001","unstructured":"Ho GH, Calvano JE, Bisogna M, Abouezzi Z, Borgen PI, Cordon-Cardo C, van Zee KJ: Genetic alterations of the p14ARF-hdm2-p53 regulatory pathway in breast carcinoma. Breast Cancer Res Treat. 2001, 65: 225-232. 10.1023\/A:1010686518990.","journal-title":"Breast Cancer Res Treat"},{"key":"430_CR27","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/0959-8049(94)90128-7","volume":"30A","author":"B Quesnel","year":"1994","unstructured":"Quesnel B, Preudhomme C, Fournier J, Fenaux P, Peyrat JP: MDM2 gene amplification in human breast cancer. Eur J Cancer. 1994, 30A: 982-984.","journal-title":"Eur J Cancer"},{"key":"430_CR28","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1038\/sj.onc.1204617","volume":"20","author":"J Silva","year":"2001","unstructured":"Silva J, Dominguez G, Silva JM, Garcia JM, Gallego I, Corbacho C, Provencio M, Espana P, Bonilla F: Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer. Oncogene. 2001, 20: 4586-4590. 10.1038\/sj.onc.1204617.","journal-title":"Oncogene"},{"key":"430_CR29","first-page":"167","volume":"150","author":"J Lukas","year":"1997","unstructured":"Lukas J, Groshen S, Saffari B, Niu N, Reless A, Wen WH, Felix J, Jones LA, Hall FL, Press MF: WAF1\/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary and endometrium. Am J Pathol. 1997, 150: 167-175.","journal-title":"Am J Pathol"},{"key":"430_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1023\/A:1005752829260","volume":"43","author":"SG Diab","year":"1997","unstructured":"Diab SG, Yu YY, Hilsenbeck SG, Allred DC, Elledge RM: WAF1\/CIP1 protein expression in human breast tumours. Breast Cancer Res Treat. 1997, 43: 99-103. 10.1023\/A:1005752829260.","journal-title":"Breast Cancer Res Treat"},{"key":"430_CR31","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1038\/sj.onc.1204993","volume":"20","author":"M Gentile","year":"2001","unstructured":"Gentile M, Ahnstrom M, Schon F, Wingren S: Candidate tumour suppressor genes at 11q23-q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis. Oncogene. 2001, 20: 7753-7760. 10.1038\/sj\/onc\/1204993.","journal-title":"Oncogene"},{"key":"430_CR32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1097-2765(01)00367-7","volume":"8","author":"Y Samuels-Lev","year":"2001","unstructured":"Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T, Lu X: ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell. 2001, 8: 781-794.","journal-title":"Mol Cell"},{"key":"430_CR33","first-page":"5656","volume":"59","author":"DC Sgroi","year":"1999","unstructured":"Sgroi DC, Teng S, Robinson G, LeVangie R, Hudson JR, Elkahloun AG: In vivo gene expression profile analysis of human breast cancer progression. Cancer Res. 1999, 59: 5656-5661.","journal-title":"Cancer Res"},{"key":"430_CR34","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/sj.onc.1201932","volume":"16","author":"H Zhang","year":"1998","unstructured":"Zhang H, Somasundaram K, Peng Y, Tian H, Zhang H, Bi D, Weber BL, El-Deiry WS: BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene. 1998, 16: 1713-1721. 10.1038\/sj\/onc\/1201932.","journal-title":"Oncogene"},{"key":"430_CR35","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1038\/sj.onc.1202509","volume":"18","author":"A Catteau","year":"1999","unstructured":"Catteau A, Harris WH, Xu CF, Solomon E: Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene. 1999, 18: 1957-1965. 10.1038\/sj\/onc\/1202509.","journal-title":"Oncogene"},{"key":"430_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/73536","volume":"24","author":"SA Gayther","year":"2000","unstructured":"Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin S-F, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JDA, Ponder BAJ, Kouzarides T, Caldas C: Mutations truncating the EP300 acetylase in human cancers. Nat Genet. 2000, 24: 300-303. 10.1038\/73536.","journal-title":"Nat Genet"},{"key":"430_CR37","first-page":"3918","volume":"52","author":"R Mazars","year":"1992","unstructured":"Mazars R, Spinardi L, BenCheikh M, Simony-Lafontaine J, Jeanteur P, Theillet C: p53 mutations occur in aggressive breast cancer. Cancer Res. 1992, 52: 3918-3923.","journal-title":"Cancer Res"},{"key":"430_CR38","first-page":"3923","volume":"6","author":"J Alsner","year":"2000","unstructured":"Alsner J, Yilmaz M, Guldberg P, Hansen LL, Overgaard J: Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer. Clin Cancer Res. 2000, 6: 3923-3931.","journal-title":"Clin Cancer Res"},{"key":"430_CR39","first-page":"8317","volume":"61","author":"T Norberg","year":"2001","unstructured":"Norberg T, Klaar S, Karf G, Nordgren H, Holmberg L, Bergh J: Increased p53 mutation frequency during tumor progression \u2013 results from a breast cancer cohort. Cancer Res. 2001, 61: 8317-8321.","journal-title":"Cancer Res"},{"key":"430_CR40","first-page":"2256","volume":"61","author":"BK Linderholm","year":"2001","unstructured":"Linderholm BK, Lindahl T, Holmberg L, Klaar S, Lennerstrand J, Henriksson R, Bergh J: The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer. Cancer Res. 2001, 61: 2256-2260.","journal-title":"Cancer Res"},{"key":"430_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/path.948","volume":"195","author":"N Maass","year":"2001","unstructured":"Maass N, Teffner M, Rosel F, Pawaresch R, Jonat W, Nagasaki K, Rudolph P: Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol. 2001, 195: 321-326. 10.1002\/path.948.","journal-title":"J Pathol"},{"key":"430_CR42","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1074\/jbc.275.9.6051","volume":"275","author":"Z Zou","year":"2000","unstructured":"Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, Srivastava S: p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem. 2000, 275: 6051-6054. 10.1074\/jbc.275.9.6051.","journal-title":"J Biol Chem"},{"key":"430_CR43","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nm0796-811","volume":"2","author":"T Aas","year":"1996","unstructured":"Aas T, Borresen AL, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug JE, Akslen LA, Lonning PE: Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med. 1996, 2: 811-814.","journal-title":"Nat Med"},{"key":"430_CR44","first-page":"2505","volume":"61","author":"S Geisler","year":"2001","unstructured":"Geisler S, Lonning PE, Aas T, Johnsen H, Fluge O, Haugen DF, Lillehaug JR, Akslen LA, Borresen-Dale AL: Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. Cancer Res. 2001, 61: 2505-2512.","journal-title":"Cancer Res"},{"key":"430_CR45","first-page":"50","volume":"6","author":"D Kandioler-Eckersberger","year":"2000","unstructured":"Kandioler-Eckersberger D, Ludwig C, Rudas M, Kappel S, Janschek E, Wenzel C, Schlagbauer-Wadl H, Mittlbock M, Gnant M, Steger G, Jakesz R: TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients. Clin Cancer Res. 2000, 6: 50-56.","journal-title":"Clin Cancer Res"},{"key":"430_CR46","first-page":"2222","volume":"7","author":"ZM Shao","year":"2001","unstructured":"Shao ZM, Wu J, Shen ZZ, Nguyen M: p53 mutation in plasma DNA and its prognostic value in breast cancer patients. Clin Cancer Res. 2001, 7: 2222-2227.","journal-title":"Clin Cancer Res"},{"key":"430_CR47","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/bcr91","volume":"2","author":"S Metcalfe","year":"2000","unstructured":"Metcalfe S, Wheeler TK, Picken S, Negus S, Milner AJ: p53 autoantibodies in 1006 patients followed up for breast cancer. Breast Cancer Res. 2000, 2: 438-443. 10.1186\/bcr91.","journal-title":"Breast Cancer Res"},{"key":"430_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1023\/A:1010624717311","volume":"66","author":"G Dominguez","year":"2001","unstructured":"Dominguez G, Silva JM, Silva J, Garcia JM, Sanchez A, Navarro A, Gallego I, Provencio M, Espana P, Bonilla F: Wild type p73 over-expression and high-grade malignancy in breast cancer. Breast Cancer Res Treat. 2001, 66: 183-190. 10.1023\/A:1010624717311.","journal-title":"Breast Cancer Res Treat"},{"key":"430_CR49","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1097\/00000478-200108000-00010","volume":"25","author":"M Barbareschi","year":"2001","unstructured":"Barbareschi M, Pecciarini L, Cangi MG, Macri E, Rizzo A, Viale G, Doglioni C: p63, a p53 homologue is a selective marker of myoepithelial cells of the human breast. Am J Surg Pathol. 2001, 25: 1054-1060. 10.1097\/00000478-200108000-00010.","journal-title":"Am J Surg Pathol"},{"key":"430_CR50","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/35091170","volume":"412","author":"B Vogelstein","year":"2001","unstructured":"Vogelstein B, Kinzler KW: Achilles' heel of cancer?. Nature. 2001, 412: 865-866. 10.1038\/35091170.","journal-title":"Nature"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr426.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/bcr426\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr426.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T05:28:52Z","timestamp":1484717332000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["430"],"URL":"https:\/\/doi.org\/10.1186\/bcr426","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4]]},"article-number":"70"}}